Indigo Diabetes is a medtech company that develops a multi-biomarker sensor for people with diabetes.
Indigo Diabetes has raised €38M across 1 funding round from 1 investor, most recently a Series B round in Jul 2020. Based in Zwijnaarde, Belgium; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-27 | Series B |
| €38M |
| Fund+ |
| View deal → |
